H.R. 6251 · 118th Congress (2023–2025)
HERO Act
This bill establishes a grant program to provide schools with opioid overdose reversal drugs and requires reporting related to the distribution of such drugs.
First, the bill requires the Substance Abuse and Mental Health Services Administration to award competitive grants to eligible entities for (1) purchasing approved opioid overdose reversal drugs; and (2) developing and implementing educational programming or resources to promote student and community knowledge of cardiopulmonary resuscitation, drug-use prevention and intervention, and emergency responses to drug overdoses. Eligible entities include private elementary and secondary schools, local educational agencies (LEAs), charter schools that are LEAs, and consortia of LEAs.
Second, the bill requires a covered educational institution (i.e., a private school, LEA, or charter school that is an LEA) that receives federal funds to submit a description of any distribution of an opioid overdose reversal drug by such institution to the National Emergency Medical Services Information System and the Overdose Detection Mapping Application Program of the Washington/Baltimore High Intensity Drug Trafficking Area.
Show official title
To establish a grant program to provide schools with opioid overdose reversal drugs, to direct schools receiving Federal funds to report to certain Federal information systems any distribution of an opioid overdose reversal drug, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 6251’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Adam B. Schiff (D-CA-28)
- Cosponsors
9 cosponsors
6 original · 3 later
9 D
- Rep. Ann M. Kuster (D-NH-2)· Original · Nov 6, 2023
- Rep. Raul Ruiz (D-CA-25)· Original · Nov 6, 2023
- Rep. Linda T. Sánchez (D-CA-38)· Original · Nov 6, 2023
- Rep. David J. Trone (D-MD-6)· Original · Nov 6, 2023
- Rep. Jill N. Tokuda (D-HI-2)· Original · Nov 6, 2023
- Rep. Bonnie Watson Coleman (D-NJ-12)· Original · Nov 6, 2023
- Rep. Tony Cárdenas (D-CA-29)· Later · Nov 13, 2023
- Rep. Teresa Leger Fernandez (D-NM-3)· Later · Jan 25, 2024
- Del. Eleanor Holmes Norton (D-DC)· Later · Jun 3, 2024
- Policy area
- Education
- Subjects
- Congressional oversight
- Drug, alcohol, tobacco use
- Education programs funding
- Elementary and secondary education
- Emergency medical services and trauma care
- School administration
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Nov 6, 2023 – Nov 10, 2023
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
HERO Act
Display title, Short title · Introduced in House
Helping Educators Respond to Overdoses Act
Short title · Introduced in House
To establish a grant program to provide schools with opioid overdose reversal drugs, to direct schools receiving Federal funds to report to certain Federal information systems any distribution of an opioid overdose reversal drug, and for other purposes.
Official title · Introduced in House